Miravant Medical Technologies Inc.
MRVT · OTC
12/31/2004 | 12/31/2003 | 12/31/2002 | 12/31/2001 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $499 | $4,683 |
| % Growth | – | -100% | -89.3% | – |
| Cost of Goods Sold | $0 | $0 | $479 | $934 |
| Gross Profit | $0 | $0 | $20 | $3,749 |
| % Margin | – | – | 4% | 80.1% |
| R&D Expenses | $7,637 | $7,616 | $9,549 | $13,318 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5,416 | $4,620 | $5,726 | $6,078 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $13,053 | $12,236 | $15,275 | $19,396 |
| Operating Income | $13,053 | $12,236 | $15,255 | $15,647 |
| % Margin | – | – | 3,057.1% | 334.1% |
| Other Income/Exp. Net | -$2,843 | $10,344 | -$15,255 | -$15,647 |
| Pre-Tax Income | $13,127 | $22,580 | $14,667 | $16,233 |
| Tax Expense | $2,843 | -$4,771 | $705 | $755 |
| Net Income | -$15,896 | -$7,465 | -$15,960 | -$16,402 |
| % Margin | – | – | -3,198.4% | -350.2% |
| EPS | -0.48 | -0.3 | -0.78 | -0.88 |
| % Growth | -60% | 61.5% | 11.4% | – |
| EPS Diluted | -0.48 | -0.3 | -0.78 | -0.88 |
| Weighted Avg Shares Out | 32,986 | 24,704 | 20,581 | 18,647 |
| Weighted Avg Shares Out Dil | 32,986 | 24,704 | 20,581 | 18,647 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $346 | $846 | $1,702 | $1,757 |
| EBITDA | -$12,601 | -$21,734 | -$13,553 | -$13,890 |
| % Margin | – | – | -2,716% | -296.6% |